Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

AVS Bio acquires Biorbyt Ltd. for growth

PRIVATESep 23, 2026•about 4 hours ago

Acquiring Company

AVS Bio

Acquired Company

Biorbyt Ltd

NorwichManufacturingBiotechnologyHealth CareBiotechnology

Description

AVS Bio has announced the acquisition of Biorbyt Ltd., significantly expanding its product catalog and distribution capabilities. Biorbyt is recognized for its high-quality bio-reagents and advanced ecommerce platform. This acquisition enhances AVS Bio's position in the bioprocessing and biologics industries. The deal aims to support broader access to essential research products.

Company Information

Company

AVS Bio

About

Headquartered in Norwich, CT, AVS Bio is global provider of specific pathogen free (“SPF”) eggs and adjacent laboratory products and services that support the development and manufacturing of vaccines, therapeutics, and other biologics used for human and animal health. Prior to its acquisition by Arlington, the Company operated as a subsidiary of Charles River Laboratories (NYSE:CRL). The Company currently employs ~250 employees across 20+ facilities in Connecticut, New York, Illinois, Missouri, and Europe. For more information: www.avsbio.com

Fundz sees it the moment AVS Bio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AVS Bio's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Biorbyt Ltd?

Biorbyt Ltd was acquired by AVS Bio. The deal was reported on September 23, 2026. AVS Bio is privately held and operates in Manufacturing.

When did AVS Bio acquire Biorbyt Ltd?

AVS Bio's acquisition of Biorbyt Ltd was reported on September 23, 2026. AVS Bio has announced the acquisition of Biorbyt Ltd., significantly expanding its product catalog and distribution capabilities. Biorbyt is recognized for its high-quality bio-reagents and advanced ecommerce platform. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Biorbyt Ltd do?

Biorbyt Ltd. is a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life science research. It is privately held, operating in Biotechnology, and is based in Norwich.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.